ASSESS trial: Blood test for EGFR mutation in advanced non-small cell lung cancer

At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Martin Reck, MD, PhD, from LungenClinic Grosshansdorf, Grosshansdorf, Germany, discusses ASSESS, a trial of the utility of circulating-free tumor DNA in the plasma for the detection of epidermal growth factor receptor (EGFR) mutation status in patients with advanced non-small cell lung cancer.


Notice: Trying to get property of non-object in /home/vjoncology/public_html/wp-content/themes/vjoncology/single.php on line 99
Share this video  

Warning: Invalid argument supplied for foreach() in /home/vjoncology/public_html/wp-content/themes/vjoncology/single.php on line 290